InvestLog
GENB Generate Biomedicines, Inc. logo

GENB Generate Biomedicines, Inc.

Financial Services
$14.53+3.93%ClosedMarket Cap: $1.86B

As of 2026-05-25

Valuation

P/E (TTM)

—

PEG

—

P/B

-1.18

P/S

58.40

EV/EBITDA

-8.68

DCF Value

$-67.66

FCF Yield

-11.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

100.0%

Operating Margin

-737.0%

Net Margin

-637.0%

ROE

38.7%

ROA

-61.5%

ROIC

-89.4%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

PeriodRevenueGross MarginOperating IncomeNet IncomeEPSDividend
Q1 null$7.2M54.7%$-64.1M$-61.4M$——
FY null$31.9M100.0%$-235.1M$-203.2M$——
FY null$20.5M100.0%$-196.9M$-173.8M$——